ClinicalTrials.Veeva

Menu

ANSeR- The Algorithm for Neonatal Seizure Recognition Study

U

University College Cork (UCC)

Status

Completed

Conditions

Neonatal Seizures

Treatments

Device: Algorithm for Neonatal Seizure Recognition

Study type

Observational

Funder types

Other

Identifiers

NCT02160171
GB0113UCC

Details and patient eligibility

About

A Multicentre Clinical Evaluation of a Decision Support Algorithm for Neonatal Seizure Detection: ANSeR

Full description

This is a multi-centre study. It will be based on routine clinical practice but will also allow for the off-line retrospective application of ANSeR to a well-defined clinical population in order to establish the potential diagnostic utility of the algorithm.

Enrollment

240 patients

Sex

All

Ages

36+ weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

All term neonates at risk of seizures are eligible for the ANSeR study.

Neonates ≥ 36 weeks gestation will be recruited if:

They have a need for EEG monitoring.

Exclusion criteria

Consent of parents not obtained.

Trial design

240 participants in 1 patient group

Term neonates
Description:
Term neonates who are undergoing continuous video amplified Electroencephalogram (aEEG)/Electroencephalogram (EEG) monitoring for clinical purposes (e.g. because seizures were suspected, or the neonate is being treated with therapeutic hypothermia). EEGs will be analysed off line by 'Algorithm for Neonatal Seizure Recognition'
Treatment:
Device: Algorithm for Neonatal Seizure Recognition

Trial contacts and locations

6

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems